CNS Pharmaceuticals, Inc. (CNSP)

CNS Pharmaceuticals Statistics

Total Valuation

CNSP has a market cap or net worth of $5.45 million. The enterprise value is -$6.70 million.

Market Cap	5.45M
Enterprise Value	-6.70M

Important Dates

The next estimated earnings date is Friday, November 14, 2025, before market open.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	n/a

Share Statistics

CNSP has 574,580 shares outstanding.

Current Share Class	574,580
Shares Outstanding	574,580
Shares Change (YoY)	n/a
Shares Change (QoQ)	+62.89%
Owned by Insiders (%)	0.15%
Owned by Institutions (%)	1.52%
Float	525,995

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	0.34
P/TBV Ratio	0.40
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 10.22, with a Debt / Equity ratio of 0.01.

Current Ratio	10.22
Quick Ratio	8.77
Debt / Equity	0.01
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-1,009.79

Financial Efficiency

Return on equity (ROE) is -350.08% and return on invested capital (ROIC) is -214.51%.

Return on Equity (ROE)	-350.08%
Return on Assets (ROA)	-114.68%
Return on Invested Capital (ROIC)	-214.51%
Return on Capital Employed (ROCE)	-118.67%
Revenue Per Employee	n/a
Profits Per Employee	-$3.09M
Employee Count	5
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -86.78% in the last 52 weeks. The beta is 0.74, so CNSP's price volatility has been lower than the market average.

Beta (5Y)	0.74
52-Week Price Change	-86.78%
50-Day Moving Average	7.39
200-Day Moving Average	24.68
Relative Strength Index (RSI)	65.43
Average Volume (20 Days)	47,733

Short Selling Information

The latest short interest is 53,831, so 9.37% of the outstanding shares have been sold short.

Short Interest	53,831
Short Previous Month	63,568
Short % of Shares Out	9.37%
Short % of Float	10.23%
Short Ratio (days to cover)	0.70

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-15.58M
Pretax Income	-15.46M
Net Income	-15.46M
EBITDA	-15.57M
EBIT	-15.58M
Earnings Per Share (EPS)	-$85.41

Balance Sheet

The company has $12.13 million in cash and $121,767 in debt, giving a net cash position of $12.01 million or $20.90 per share.

Cash & Cash Equivalents	12.13M
Total Debt	121,767
Net Cash	12.01M
Net Cash Per Share	$20.90
Equity (Book Value)	13.12M
Book Value Per Share	26.02
Working Capital	12.75M

Cash Flow

In the last 12 months, operating cash flow was -$20.86 million and capital expenditures -$4,188, giving a free cash flow of -$20.86 million.

Operating Cash Flow	-20.86M
Capital Expenditures	-4,188
Free Cash Flow	-20.86M
FCF Per Share	-$36.31

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CNSP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-291.17%
FCF Yield	-392.91%

Analyst Forecast

The average price target for CNSP is $20.00, which is 111.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$20.00
Price Target Difference	111.00%
Analyst Consensus	Strong Buy
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-51.72%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on July 22, 2025. It was a reverse split with a ratio of 1:12.

Last Split Date	Jul 22, 2025
Split Type	Reverse
Split Ratio	1:12

Scores

Altman Z-Score	n/a
Piotroski F-Score	1